Related Experiment Video
Updated: Nov 25, 2025

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled
Scott H Kollins1, Denton J DeLoss2, Elena Cañadas2
1Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA.
Insights
This study shows that AKL-T01, a digital therapeutic, improved attention in children with ADHD. The treatment was well-tolerated, with minimal side effects observed in the trial.
Area of Science:
- Neuroscience
- Digital Therapeutics
- Pediatric Health
Background:
- Attention-deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder impacting children and families.
- Digital therapeutics offer novel approaches to address cognitive deficits in ADHD, potentially overcoming barriers to traditional treatments.
- AKL-T01 is an investigational digital therapeutic designed to improve attention and cognitive control in pediatric ADHD patients.
Purpose of the Study:
- To evaluate the efficacy of AKL-T01 in improving attentional performance in pediatric patients diagnosed with ADHD.
- To assess the safety and tolerability of AKL-T01 in the target population.
Main Methods:
- The Software Treatment for Actively Reducing Severity of ADHD (STARS-ADHD) trial was a randomized, double-blind, controlled study.
- Paediatric patients (8-12 years) with ADHD and low TOVA API scores were randomized to AKL-T01 or a digital control.
- The primary outcome was the change in Test of Variables of Attention (TOVA) Attention Performance Index (API) from baseline to post-intervention.
Main Results:
- A statistically significant improvement in TOVA API was observed in the AKL-T01 group compared to the control group (p=0.0060).
- The mean change in TOVA API was 0.93 in the AKL-T01 group versus 0.03 in the control group.
- AKL-T01 demonstrated a favorable safety profile, with mild, infrequent adverse events such as frustration and headache.
Conclusions:
- AKL-T01 shows promise as a digital intervention for improving objectively measured inattention in pediatric ADHD.
- The digital therapeutic was well-tolerated, with minimal adverse events reported.
- Further research is warranted to fully establish the role of AKL-T01 in ADHD management.
Background:
Attention-deficit hyperactivity disorder (ADHD) is a common paediatric neurodevelopmental disorder with substantial effect on families and society. Alternatives to traditional care, including novel digital therapeutics, have shown promise to remediate cognitive deficits associated with this disorder and may address barriers to standard therapies, such as pharmacological interventions and behavioural therapy. AKL-T01 is an investigational digital therapeutic designed to target attention and cognitive control delivered through a video game-like interface via at-home play for 25 min per day, 5 days per week for 4 weeks. This study aimed to assess whether AKL-T01 improved attentional performance in paediatric patients with ADHD.
Methods:
The Software Treatment for Actively Reducing Severity of ADHD (STARS-ADHD) was a randomised, double-blind, parallel-group, controlled trial of paediatric patients (aged 8-12 years, without disorder-related medications) with confirmed ADHD and Test of Variables of Attention (TOVA) Attention Performance Index (API) scores of -1·8 and below done by 20 research institutions in the USA. Patients were randomly assigned 1:1 to AKL-T01 or a digital control intervention. The primary outcome was mean change in TOVA API from pre-intervention to post-intervention. Safety, tolerability, and compliance were also assessed. Analyses were done in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, NCT02674633 and is completed.
Findings:
Between July 15, 2016, and Nov 30, 2017, 857 patients were evaluated and 348 were randomly assigned to receive AKL-T01 or control. Among patients who received AKL-T01 (n=180 [52%]; mean [SD] age, 9·7 [1·3] years) or control (n=168 [48%]; mean [SD] age, 9·6 [1·3] years), the non-parametric estimate of the population median change from baseline TOVA API was 0·88 (95% CI 0·24-1·49; p=0·0060). The mean (SD) change from baseline on the TOVA API was 0·93 (3·15) in the AKL-T01 group and 0·03 (3·16) in the control group. There were no serious adverse events or discontinuations. Treatment-related adverse events were mild and included frustration (5 [3%] of 180) and headache (3 [2%] of 180). Patient compliance was a mean of 83 (83%) of 100 expected sessions played (SD, 29·2 sessions).
Interpretation:
Although future research is needed for this digital intervention, this study provides evidence that AKL-T01 might be used to improve objectively measured inattention in paediatric patients with ADHD, while presenting minimal adverse events.
Funding:
Sponsored by Akili Interactive Labs.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Behavior Modification
A real-world application of operant conditioning principles is applied...